Newdays
newdays.ai
Telemedicine & Virtual Care
Digital Therapeutics
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$11.5M
2 rounds on record
Latest round
$4.5M
Venture round · Oct 2025 · 12 mo ago
Team
11-50
employees, estimated range
Backers
2
General Catalyst, Madrona
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
2 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 9, 2025
Raised a round Venture round $4.5M · GeekWire
Sep 3, 2025
Raised a round Venture round $7M · led by General Catalyst · MedCity News
2024
Founded
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | $4.5M | — | GeekWire |
| Venture round | Sep 2025 | $7M | General Catalyst lead, Madrona lead | MedCity News |
Registers and programsofficial lists and records that name the company
| Legal entity | NewDays, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Babak ParvizExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
General Catalyst 
Madrona Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Emocog is a Korean healthcare startup that develops AI-based digital therapeutics for preventing and treating dementia and cognitive…
Neuroglee develops digital therapeutics for people with early Alzheimer's disease and mild cognitive impairment. Its programmes combine…
Clinical-grade cognitive assessment at home. No referral needed. Reviewed by specialists. Detect mild cognitive impairment early. Results…
Measure Milder Cognitive Dysfunction and Plan More Targeted Care.
Implement and manage patient journeys to provide a personalised healthcare experience for all stages of life.
TimelyCare is the only clinically accountable virtual health provider built for education, providing 24/7 care and proven student outcomes.
News
Act Two: After the Diagnosis
Families can feel lost after a dementia diagnosis. We explore the options to maintain function, from the oldest habits to the newest drugs and therapies.
Read more
Report
Ad paid and presented by NewDays. Rethinking dementia care
Newdays on how AI and cognitive training is trying to reshape dementia care
Read more
Report
Use Cognitive Simulation Therapy at Home: Three Tips / Dementias
We're sharing insights about cognitive stimulation therapy (CST) from Dr. Daniel Fenton, head of neuropsychological services at New Days, a virtual clinic specializing in care for people with mild cognitive impairment and early-stage dementia.
Read more
Report
Delaying Dementia Symptoms
NewDays is a science-backed, non-drug approach to help maintain cognitive function, build confidence, and maintain relationships.
Read more
Report
Report
NewDays raises additional $4.5M for platform that uses generative AI to treat people with dementia
The startup offers telehealth visits with clinicians once or twice a month combined with frequent, personalized conversations with an AI companion called Sunny.
Read more
Report
NewDays Secures $7M To Expand Treatment for Cognitive Impairment, Dementia
NewDays' $7 million seed round was led by General Catalyst and Madrona. The funds will be used to expand into additional states and grow its team.
Read more
Report
People
Babak Parviz
Executive Officer, Director
Tim Porter
Director
Holly Maloney
Director
Daniel Kelly
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Seattle
United States
HQ
10-50 est. staff